QIAstat-Dx uses real-time PCR technology to multiply genetic targets within the same reaction and deliver test results in around one hour.

Shigella and Yersinia enterocolitica – for FDA clearance in the coming weeks, and also intends to submit QIAstat-Dx Rise, a higher-capacity version of its diagnostic system, for approval by the ...